[Infections in Patients with Home Ventilation]

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Patients requiring home ventilation have an increased susceptibility to lower respiratory tract infections, including pneumonia.
• Distinguishing between tracheobronchitis and pneumonia can be challenging in this population.
• Comorbidities often contribute to severe disease courses in patients with home ventilation.

Purpose of the Study:

• To address the lack of established recommendations for initial empiric antimicrobial therapy in patients with home ventilation.
• To highlight the importance of considering multi-drug resistance (MDR) risk factors in treatment selection.
• To outline essential principles for antimicrobial therapy in home ventilation settings.

Main Methods:

• Review of existing knowledge on respiratory infections in home ventilation.
• Emphasis on risk factor assessment for multi-drug resistance (MDR).
• Application of general antimicrobial therapy principles: judicious use, dosing, diagnostics, de-escalation, and duration.

Main Results:

• No specific guidelines exist for initial empiric antimicrobial therapy in home ventilation patients.
• Multi-drug resistance (MDR) risk factors are frequently present and necessitate careful consideration.
• Inhaled antimicrobials may be an option in select cases.

Conclusions:

• Adherence to hygienic standards is paramount for preventing lower airway infections.
• Minimizing invasive ventilation and attempting weaning are crucial to reduce pneumonia risk.
• Antimicrobial therapy principles, including appropriate indication, dosing, and de-escalation, are vital for effective management.